chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weakness; 80% blockage of the carotid artery; Could not walk; chills; A spontaneous report was received from a consumer regarding her spouse, a 70-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced 80% blockage of the carotid artery/carotid artery occlusion, could not walk/gait disturbance. Weakness/asthenia and chills.  The patient's medical history was not included. Products known to have been used by the patient were not provided.  On 20 January 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 29 January 2021, approximately ten days after the mRNA-1273 vaccine was given, the patient experienced 80% blockage of the carotid artery, he could not walk, weakness and chills. He was taken to the emergency room, where he was admitted for two weeks. During this time, he had carotid artery surgery. His primary care doctor could not confirm whether he had a TIA. The consulting neurologist thought the symptoms might be related to the vaccine.   Action taken with mRNA-1273 was not reported.  The outcome of the events, 80% blockage of the carotid artery, he could not walk, weakness and chills, were considered unknown.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
pt recv vax & devel T104, n/v, malaise, arthralgia, platelets dec 500,000 to 145,000;
In December 2021, patient didn't get a menstrual period.  On January 14, she started her menstrual cycle which lasted 34 days.  In March and April 2022, menstrual cycle appeared normal.  In May 2022, the patient had amenorrhea again. On June 5,2022, the patient started her period and continued until July 9th, 2022.  Starting in August 2022, patient now experiences 21 day menstrual cycles. Bleeding is become worse but abdominal cramping has decreased with periods.
Right thigh - site of injection - 6" x 7.5" of erythema and induration, warm to touch - observe, cool compresses, ibuprofen.
Diarrhea; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 23-year-old-female non pregnant patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration on 28Apr2021 at 00:00 (at the age of 23-year-old), for COVID-19 immunisation. Medical history of the patient and concomitant medications was not reported. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. On unknown date the patient experienced diarrhea. The clinical outcome of the event diarrhea was unknown at the time of reporting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report was being submitted to amend previously reported information: The start and stop date/time of BNT162B2 were updated as 28Aapr2021 00:00.
pt began to feel hot, flushed & itchy about 30min p/vax; no swelling or extreme redness noted @ inj site;
pain on his left hand; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 54-year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, single; Location: left arm), for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "pain on his left hand". Therapeutic measures were taken as a result of pain in extremity. Additional information: Reporter says he took the first and second one and since he took that he has had pain on his left hand. He says the left-hand pain started after his second dose, about 3-4 days later. AE Treatment: He said for his hand pain he took Tylenol, or Motrin sometimes. He doesn't remember the dosage for those medications. He says for the Tylenol he took extra strength, which he took 2-3 times, each time two pills, as needed for the pain. AE Outcome: He said that the left-hand pain died down for a bit then would come back after the medicine was not working anymore, so he would try the next dose which killed the pain and then after four to five hours it would come back when it was time for the next dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 24 hrs of getting FLUZONE vaccine, student unable to comfortably move arm, has discomfort from  (L) axillary to (L) elbow. Some redness at site
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored PEDVAXHIB (lot# L042836 with expiration date 24-AUG-2018, lot# L051124 with expiration date 14-OCT-2018, lot # L042257 with expiration date 17-AUG-2018, lot# L051123 with expiration date 13-OCT-2018, intramuscular; dose unspecified), which were exposed to temperature excursion of 48.2 Fahrenheit degree (F) for 10 hours because of data logger. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Narrative: Pt had erythematous, warm, swollen softball size area at the injection site. She was instructed to take OTC Benadryl and use heat packs for relief. Pt was also instructed not to receive any more COVID vaccines.
3inch in diameter red mark and lump noted immediately.  Two weeks out my arm was still sore to touch and arm is still red.
Swelling and redness outer aspect R thigh-from hip to knee-warm to touch. Low grade fever x 3 days.
transient ischemic event also known as a mini stroke; This spontaneous case was reported by a consumer and describes the occurrence of TRANSIENT ISCHAEMIC ATTACK (transient ischemic event also known as a mini stroke) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TRANSIENT ISCHAEMIC ATTACK (transient ischemic event also known as a mini stroke) (seriousness criterion medically significant). At the time of the report, TRANSIENT ISCHAEMIC ATTACK (transient ischemic event also known as a mini stroke) outcome was unknown.            The patient experienced Transient Ischemic attack also known as a mini stroke after the second dose and went to ER.  No concomitant medications were reported. No treatment medications were reported.  Very limited information regarding the event  has been provided at this time.; Sender's Comments: Very limited information regarding the event  has been provided at this time.
At 11:00 pm I had an extremely intense seizure that caused me to convulse on the floor while arching my back. My partner thought I was dying as it was much more intense and extreme then normal. I am still having increased seizures in both pain and severity daily. Typically my seizures last 20 minutes and are from 4-5 in discomfort in pain out of ten. Now they are around 7, even a week later. The first severe seizure was a 10 level pain and diabling.   I also got severe swelling in my arm of the site, extreme pain in the my arm lasting four days, and two large cold sores. Typically my cold sores small and last for two days. Mine are still active and gave me a fat lip. I also have extreme fatigue but could be caused by the increased seizures and pain of them.   I been unable to perform my normal duties and responsibilities, which my seizures typically do not interfere with.
p/vax pt exp inj site swelling & 3 macular lesions on stomach;pt sought unspecified medical attention;
Started with moderate arm pain about 11 hours after injection.  Progressed to fatigue, moderate muscle and joint pain and slight fever over the next 12 hours.  Felt terrible for about 24 hours and slowly began to feel better within 48 hours.
I had fever, body ache, chills, sore throat, fatigue, and severe cough. These lasted for about 7 days. On Jan 13th, I tested positive for COVID-19.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant product use was reported. Patient received half dose. The vial was initially stored in the refrigerator on 4Jun2022. Vial did not undergo any temperature excursions.  No treatment information was provided.
PT RECEIVED FIRST DOSE OF PFIZER ON 5/16. PT IS HERE FOR SECOND DOSE (9 DAYS EARLY). THE ERROR WAS NOT REALIZED UNTIL THE CARD WAS CHECKED BY MONITORING STAFF AFTER VACCINATION. FATHER WAS INFORMED OF ERROR.
This spontaneous report as received from certified medical assistant refers to a patient of unknown age. The patient was vaccinated with dose 1 GARDASIL (lot #, dose and route not reported) on an unspecified date in 2011. The patient received dose 2 of GARDASIL (lot #, dose and route not reported) on an unspecified date in July 2012. No adverse effects were reported. Additional information has been requested.
Lumps on both hands.; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Lumps on both hands.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced MASS (Lumps on both hands.). At the time of the report, MASS (Lumps on both hands.) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable. Treatment information includes Short-term antibiotics and ice packs   This case was linked to US-MODERNATX, INC.-MOD-2021-083098 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083098:case for second dose
Fatigue, slight nausea, slight dizziness, generally under the weather Started several hours after injection, lasted about 2 days, particularly fatigue I typically feel "under the weather"  for a day or 2 after most vaccines, including flu, shingles, pneumonia
Immunization TDAP 7/25/14. Reaction noted at 7/29/14. Diagnosis: Cellulitis Tx: KEFLEX.
The patient developed rapid heart rate (>120bmp) at rest about 20 minutes following vaccination.  She called the ambulance around 2-3pm  and went to the ER.  A cocktail steroid, benadryl, pepcid given at the emergency room and gave a bag of fluids.  The patient went back last night (4/26/21) b/c she woke up  in the middle of the night and HR was 150bmp.  They monitored her and sent her home.  All the tests/labs were good and the medical staff attributed the tachycardia to the vaccine. The patient's heart rate is back to normal at around 69 bpm.
pt recv vax 1995 & lab eval approx MAR97 revealed lack of response;
Arm tenderness at injection site.  Ice pack and 2 Advil 200 mg  Was fine by 11:30.  Woke up about 6:00 next morning  felt fine. No further issues.
Positive URTICARIA - stated day of vaccine administration 11/2/07, on legs, spread to other areas by 11/3/07
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer concerning a 68 year old female patient There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 14-APR-2011, the patient was administered the ZOSTAVAX (lot number, expiration, dose and route unknown) by a pharmacist at a pharmacy. In July 2015, the patient was treated by the patient's healthcare provider at a medical center for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The patient claims damages as a result of injury to self, loss of services and economic losses. The outcome of the event is unknown. The causality of the event is related. Additional information has been requested.
Severe pain in right shoulder, trapezoid and right side of neck, radiating about 4-6 inches down my spine.  Same pain in left side, but started a few days later, and not as painful.  I think the vaccine is reacting with the Botox I get four times a year for migraines because the pain is in the same areas in my shoulders and neck.  I received my vaccine shot in right arm.
Weakness, fatigue, muscle aches, starting 3 days after first COVID Moderna vaccine, then worsened to fatigue causing her to stay in bed.  Some bleeding gums on brushing, no other bleeding or ecchymosis noted. She went to hospital 2 weeks after vaccine. Myocarditis diagnosed in hospital  with elevated troponins, also  thrombocytopenia and elevated D Dimer.
9/12/01 evening red area and itching. 9/13/01 Red area on arm swelled to size of dime. 9/14/01 red area on arm swelled to size of a half dollar. Mother gave child Advil.
Starting the day of the DTaP vaccine She ran a fever of 103 for 3 days, excessive  crying, not  eating  or sleeping for   3 days.  Pt. was given ibuprofen
I received the Covid 19 Booster dose on Wednesday 10-27-21. The next morning I had minor cold like symptoms that started with chills and turned into a cough by Saturday 10-30-21. My chest began to hurt on that date and I presumed it was because of the cough. The chest pain and cough continued to get worse so I went to Urgent care on Tuesday 11-2-21. They performed an EKG and provided a cough medicine. The chest pain continued to get worse until finally on 11-8-21 I was convinced that I was having a heart attack. I went to the ER at Hospital. They had to perform a heart catherization and put in a stint because of a blood clot in my LAD artery. Dr said that there wasn't any plaque or buildup, but rather a bloodclot that caused the heart attack.
Pt noticed to have rash that was spreading. Pt was isolated immediately and placed on contact/airborne precautions d/t concerns for chickenpox.
My whole upper left arm hurts, and the pain worsens when I move it. I also feel weak in my left arm.  The right side of my lower jaw hurts, and it worsens with movement. I took Tylenol, but it did not alleviate the pain.
Swelling at injection site, target/circle type redness around injection site, itching at injection site, rash with itch on top of left shoulder
Patient presented c/o 12 hours squeezing chest pain.  Presented on Day 12 post first time smallpox vaccination (positive take).  Had similar pain 2 days prior.  Evaluation revealed laboratory and history consistent with myo/pericarditis without decrease in cardiac function at time of admission.  Treated via admission, NSAIDs, observation, rest, supplemental O2 (no O2 requirement though).  Today is date of admission. 60-day follow up on 02/11/04: "It is unknown whether the pt recovered from the adverse events. We cannot say that he has recovered until after his 2 year follow up."
Narrative:  Patient received Moderna COVID #1 on 1/20/21 and #2 on 2/17/21. No information in chart on what happened from date of second vaccine to date of death of 3/31/21. Time from second vaccine to date of death is 42 days. No autopsy report available.
The injection site has become increasingly painful as time goes on. It feels l like my shoulder muscle is 'dying'  if that makes sense.  definite increasing weakness in  my shoulder and arm ,  pain radiating out deep in the muscle right at the  injection  site ,
Mom states pt devel flat pinpoint red rash inner area of knees, outsides of arms near elbow areas & also flat reddened area on abdomen; lasted 3 days; Also had first intro of green beans that wk; was lying on blanket on rug;
SERIOUS REACTIONS; This spontaneous report received from a vaccine facility via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 16-MAR-2021, the subject experienced serious reactions. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of serious reactions was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Pretty severe body aches; Fatigue; Headache; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 09Apr2021 at 10:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety, gastroesophageal reflux disease (GERD), migraine and COVID-19. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), propranolol (MANUFACTURER UNKNOWN), buspirone hydrochloride (BUSPAR), omeprazole (MANUFACTURER UNKNOWN) and cynara cardunculus; malus spp. vinegar extract; taraxacum officinale (apple cider) (MANUFACTURER UNKNOWN), all used for unknown indication and from an unknown date. The patient previously took morphine and Norco and experienced allergy to the drugs. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 11:00, the patient experienced pretty severe body aches, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pretty severe body aches, fatigue and headache was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Sore arm post-shot continues 10 days following shot. Immediate onset, not delayed onset.
She thinks she had Afib; Heart rate went up; Symptoms were similar to when she had COVID; Temperature of 99 degrees; Severe Headache; Very fatigued, which is unlike her; A spontaneous report was received from a Consumer concerning a unknown Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events- severe headache, had a temperature of 99 degrees, was very fatigued, atrial fibrillation, increased heart rate and recurrence of Covid-19 symptoms.   The patient's medical history includes Covid-19, she was on a pacemaker.  Relevant concomitant medications reported include patient was taking Diltiazem 120 ER.    On 26 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced severe headache, had a temperature of 99 degrees, was very fatigued, which was unlike her, she thinks she had atrial fibrillation (seriousness criteria- medically significant) and increased heart rate. She said her symptoms was similar to when she had Covid-19. Patient is on a pacemaker   Laboratory details include she had a body temperature of 99 degrees.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the events- severe headache, had a temperature of 99 degrees, was very fatigued, atrial fibrillation, increased heart rate and recurrence of Covid-19 symptoms was considered unknown.; Reporter's Comments: This case concerns a 72 year old, female patient, COVID (March 2020) and has a pacemaker, who experienced a serious unexpected event of Atrial fibrillation among others, 1 day after receiving 1st dose of mRNA- 1273 (Lot# unknown). Very limited information regarding this event has been provided at this time. Further information has been requested.